Rachel C. Jinks

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

Jeremy Whelan, Rachel C. Jinks, Anne McTiernan et al. · Annals of Oncology · 2011 · 201 citations · Full text

Prognostic Factors, Surgical Oncology, Extremity Osteosarcoma +6

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)

Ruth E. Langley, Fay Cafferty, Abdulla Alhasso et al. · The Lancet Oncology · 2013 · 91 citations · Full text

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup

Anne McTiernan, Rachel C. Jinks, Matthew R. Sydes et al. · European Journal of Cancer · 2011 · 50 citations · Full text

Discrimination-based sample size calculations for multivariable prognostic models for time-to-event data

Rachel C. Jinks, Patrick Royston, Mahesh Parmar · BMC Medical Research Methodology · 2015 · 31 citations · Full text

Measuring the impact of methodological research: a framework and methods to identify evidence of impact

Valerie Brueton, Claire L. Vale, Babak Choodari‐Oskooei et al. · Trials · 2014 · 21 citations · Full text